Gentherm (THRM) Misses Q4 EPS by 17c; Offers FY23 Guidance

Gentherm (NASDAQ: THRM) reported Q4 EPS of $0.47, $0.17 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $343.3 million versus the consensus estimate of $342.46 million.

The company sees FY23 product revenues between $1.45 billion and $1.55 billion.

For earnings history and earnings-related data on Gentherm (THRM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c